George K. Ng
Known title: Chief Executive OfficerCIK: 0001638744
George K. Ng's purchase track record
How the stock did after each of George K. Ng's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 9 since January 30, 2024
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-37.9%
3 months: -19.3%
Beat the S&P 500
0%
median -51.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/1/2026 | PCSA | $6K | -12.8% | pending | — |
| 6/15/2026 | PCSA | $5K | -14.0% | pending | — |
| 5/29/2026 | PCSA | $5K | -19.1% | pending | — |
| 5/15/2026 | PCSA | $5K | -17.9% | pending | — |
| 4/30/2026 | PCSA | $5K | -24.4% | pending | — |
| 4/15/2026 | PCSA | $5K | -19.3% | -45.4% | +9.9% |
| 3/31/2026 | PCSA | $5K | -24.0% | -30.3% | +17.5% |
| 1/27/2025 | PCSA | $70K | -61.6% | -62.1% | +6.3% |
| 1/30/2024 | PCSA | $27K | -19.3% | -15.6% | +10.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PCSA | ▲ Buy | Option Exercise | 1,600 | — | 8/8/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 3,057 | $6K | 7/1/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 2,465 | $5K | 6/15/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 2,129 | $5K | 5/29/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 1,843 | $5K | 5/15/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 2,034 | $5K | 4/30/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 1,843 | $5K | 4/15/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 2,136 | $5K | 3/31/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 87,200 | $70K | 1/27/2025 | View on chart |
| PCSA | ▲ Buy | Open Market | 10,000 | $27K | 1/30/2024 | View on chart |
| PCSA | ▲ Buy | Grant | 100,000 | $25K | 10/12/2023 | View on chart |
| PCSA | ▲ Buy | Grant | 100,000 | $25K | 10/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Processa Files Prospectus for 306.5M Share Offering
Processa Pharmaceuticals filed a prospectus for an offering of 306.574 million common shares on behalf of selling shareholders. This large-scale secondary offering adds significant supply to the market, which may pressure the stock price. The company is currently trading near the lower end of its 52-week range, with technical indicators showing weakness.
Processa Files Prospectus for 306.5M Share Offering. Processa Pharmaceuticals filed a prospectus for an offering of 306.574 million common shares on behalf of selling shareholders. This large-scale secondary offering adds significant supply to the market, which may pressure the stock price. The company is currently trading near the lower end of its 52-week range, with technical indicators showing weakness.